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Background: Previous studies examining the metabolic consequences of dietary iron deficiency have reported
elevated serum glucose concentrations in iron-deficient animals. Importantly, the majority of these findings were
observed using an earlier version of a laboratory animal diet (AIN-76A) in which the primary carbohydrate source
was sucrose – a disaccharide known to negatively impact both glucose and lipid homeostasis. The AIN-76A diet
formula was improved in 1993 (AIN-93) to optimize animal nutrition with a major change being the substitution of
cornstarch for sucrose. Therefore, we sought to examine the effects of iron deficiency on steady-state glucose
homeostasis and the hepatic expression of glucose- and lipid-related genes in rats fed an iron-deficient diet based
on either an AIN-76A or AIN-93 diet.
Methods: The study design consisted of 6 treatment groups: control (C; 40 mg Fe/kg diet), iron deficient (ID;
≤ 3 mg Fe/kg diet), or pair-fed (PF; 40 mg Fe/kg) fed either an AIN-76A or AIN-93 diet for 21 d. Hemoglobin and
hematocrit were measured in whole blood. Serum insulin and cortisol were measure by ELISA. Serum glucose and
triacylglycerols were measured by standard colorimetric enzyme assays. Alterations in hepatic gene expression
were determined by real-time qPCR.
Results: Hemoglobin and hematocrit were significantly reduced in both ID groups compared to the C and PF
groups. Similarly, animals in the both ID groups exhibited elevated steady-state levels of blood glucose and insulin,
and significantly decreased levels of circulating cortisol compared to their respective PF controls. Serum
triacyglycerols were only increased in ID animals consuming the AIN-76A diet. Hepatic gene expression analyses
revealed a ~4- and 3-fold increase in the expression of glucokinase and pyruvate dehydrogenase kinase-4 mRNA,
respectively, in the ID group on either diet compared to their respective PF counterparts. In contrast, the expression
of lipogenic genes was significantly elevated in the AIN-76 ID group, while expression of these genes was
unaffected by iron status in the AIN-93 ID group.
Conclusions: These results indicate that an impaired iron status is sufficient to alter glucose homeostasis, though
alterations in lipid metabolism associated with ID are only observed in animals receiving the AIN-76A diet.
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Iron is an essential nutrient found in abundance in the
earth’s crust, yet iron deficiency remains the most com-
mon micronutrient deficiency in the world [1]. Symp-
toms of iron deficiency include weakness, fatigue,
impaired immune function, and reduced cognitive func-
tion in children. In animal models, less well character-
ized responses to iron deficiency include alterations in
lipid and glucose metabolism arising from decreased
oxidative capacity which leads to a shift in preferential
fuel utilization from fat to glucose [2-4]. Iron-deficient
animals also display signs of disrupted metabolic
homeostasis, including alterations in insulin signaling,
as evidenced by hyperglycemia, hyperinsulinemia, and
hyperlipidemia [2,5].
Determining the molecular mechanisms contributing
to the hyperglycemic and hyperinsulinemic responses
observed in response to dietary iron deficiency is made
more complicated since many of the observations in glu-
cose metabolism were noted prior to the 1993 American
Institute of Nutrition (AIN) reformulation (AIN-93) of
the AIN-76A laboratory animal diet, which is simply re-
ferred to as AIN-76 in the present study. The AIN-93
rodent diets were formulated to improve animal per-
formance in experimental models with a major change
being the substitution of cornstarch for sucrose because
high dietary concentrations of sucrose were associated
with several metabolic complications including hyperlip-
idemia, hyperinsulinemia, and fatty liver [6,7]. Therefore,
it is difficult to discern the extent to which the metabolic
consequences observed in previous studies noting dis-
ruptions in metabolic homeostasis were indeed an effect
of iron deficiency alone, or rather the effect of dietary
carbohydrate (i.e., sucrose) on glucose and lipid metabol-
ism in iron-deficient animals.
Another factor complicating the investigation into the
metabolic response to iron deficiency is that the severity
of these consequences (i.e., hyperglycemia and hyperlip-
idemia) appears to be a graded response associated with
a reduction in hemoglobin [8]. Hemoglobin levels indi-
cative of anemia are associated with elevated plasma
triacylglycerols (TAG) and glucose, though less severe
reductions in hemoglobin are not as highly correlated
with hyperlipidemia and hyperglycemia suggesting that a
certain threshold exists in order to develop these poten-
tially negative metabolic consequences [8-10]. In con-
trast, neither hyperglycemia nor hyperlipidemia were
observed at varying levels of anemia in animals fed an
AIN-93 based diet, although both glucose utilization and
insulin responsiveness appeared to be enhanced [2].
More recently, two studies reported elevated serum glu-
cose and TAG levels in severely iron-deficient
(hemoglobin < 60 g/L) rodents fed an AIN-93 diet, but
the underlying mechanisms contributing to thesemetabolic responses were not the primary focus of these
investigations [11,12]. Thus, it remains unclear if
these mixed observations from previous studies
are more attributable to the severity of iron deficiency
elicited in the animal model, or are instead the result of
a carbohydrate-specific response to an iron-deficient
diet.
The focus of the current study was to examine the ex-
tent to which an impaired iron status is associated with
alterations in metabolic homeostasis and changes in
hepatic lipogenic gene expression in rats fed iron-
deficient diets based on either the AIN-76 or AIN-93
formulations. Animals in the iron-deficient groups, re-
gardless of carbohydrate source, exhibited elevated levels
of steady-state serum glucose and insulin. Interestingly,
serum TAG and the relative abundance of mRNA en-
coding proteins responsible for regulating de novo lipo-
genesis in the liver was increased only in iron-deficient
rats receiving the AIN-76 diet. The results presented
herein support a model wherein alterations in glucose
homeostasis observed in iron-deficient animals are inde-
pendent of dietary carbohydrate whereas alterations in
lipid metabolism appear to be dependent of dietary
carbohydrate present in the AIN-76 diet. Thus, it is es-
sential to consider the metabolic consequences of diets




Forty-eighty 21-d-old weanling male Sprague–Dawley
(Harlan, IN) rats were housed individually at the Okla-
homa State University (OSU) Laboratory Animal Re-
search facility in a temperature- and humidity-controlled
environment and maintained on a 12 h light:dark cycle
with ad libitum access to deionized water. Upon arrival
at the animal facility, rats were randomly assigned to ei-
ther the AIN-76 (n=24) or AIN-93G (n=24) arm of the
study (Table 1). Rats in each group were allowed ad libi-
tum access to their respective control diet for 3 d prior
to starting dietary treatments. After the acclimation
period, rats in each group were assigned to one of three
treatments (n=8/treatment) for 21 d: control (76-C or
93-C; 40 mg Fe/kg diet), iron-deficient (76-ID or 93-ID;
≤ 3 mg Fe/kg diet), or pair-fed (76-PF or 93-PF; each
were fed their respective control (40 mg Fe/kg diet) diets
at the level of intake of their ID counterparts). Commer-
cially available powdered diets (76-C-TD.89300, 76-ID-
TD.80396, 93-C-TD.94045, and 93-ID-TD.09564) were
purchased from Harlan Teklad (Madison, WI). The pri-
mary differences between the AIN-76 and AIN-93 diets
pertinent to the current study are shown in Table 1.
Whereas cellulose was notably absent from the 93-ID in
an effort to prevent iron contamination, the 93-C diet
Table 1 Composition of AIN-76 and AIN-93 diets1




Corn Starch 150 447
Maltodextrin — 132
Sucrose 550 100
Soybean Oil — 70
Corn Oil 50 —
Mineral Mix2 35 35
Vitamin Mix 10 10
Choline Bitartrate 2 2.5
TBHQ, antioxidant — 0.014
Ethoxyquin 0.01 —
1The 93-C diet contained 397 g/kg corn starch with an added 50 g/kg
cellulose. Cellulose was removed from the 93-ID and both AIN-76 diets to
prevent contamination with additional iron.
2Mineral mixes were adjusted such that the ID diets contained ≤ 3 mg Fe/kg
diet, and the C diets contained ~40 mg Fe/kg diet.
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shown that this level of cellulose (5% w/w) does not ad-
versely affect apparent absorption of iron [13]. Individual
body weights and food intake were measured daily. After
the 21 d experimental period, rats were anesthetized
with a mixture of ketamine/xylazine and killed by exsan-
guination between 8:00 and 10:00 a.m. Food intake was
not restricted prior to sacrifice. All animal handling and
procedures were approved by the Institutional Animal
Care and Use Committee at OSU.
Assessment of iron status
Whole blood was collected from the abdominal aorta
into EDTA-coated tubes and sent to a commercial la-
boratory (Antech Diagnostics, Inc. Irvine, CA) for deter-
mination of hemoglobin and hematocrit. A sample of
whole blood was also collected into serum tubes,
allowed to clot, centrifuged at 800 x g for 20 min at 4°C
to separate the serum, and then stored at −80°C until
further analyses. Serum iron was determined using
an ELAN 9000 ICP-Mass Spectrometer (PerkinElmer,
Norwalk, CT). Microanalysis of non-heme iron in liver
was determined as described by Rebouche et al. [14].
Metabolic indices
Serum glucose was measured using a glucose oxidase kit
(Sigma-Aldrich, St. Louis, MO) according to the manu-
facturer’s instructions, except that reaction volumes were
scaled down to a final volume of 1 mL. Serum was
diluted 1:80 (v/v) so that results obtained were within
the detectable range of the assay and standard curve.
Serum insulin (Crystal Chem, Inc., Downers Grove, IL)
and cortisol (R&D Systems, Minneapolis, MN) weremeasured by ELISA according to the manufacturer’s
instructions. Serum TAG levels were measured using a
standard colorimetric assay based on the enzymatic hy-
drolysis of triacylglycerol to glycerol and free fatty acids
by lipase (Sigma-Aldrich, St. Louis, MO). For all assays,
serum samples with obvious signs of hemolysis were
excluded from analyses.Pathway-focused PCR array and qPCR
Changes in gene expression were analyzed by a
pathway-focused Glucose Metabolism PCR array
(SABiosciences, Valencia, CA). Briefly, total RNA was
isolated from ~ 100 mg whole liver using STAT-60
(Teltest, Inc., Friendswood, TX). RNA concentration and
integrity were determined using a Nanodrop spectro-
photometer (Thermo Fischer Scientific, Middletown,
VA) and agarose gel electrophoresis, respectively. Total
RNA was then treated with DNase I, reverse-transcribed
using SuperScript II (Invitrogen, Grand Island, NY), and
brought to a final volume of 120 μL. The cDNA from in-
dividual animals was used as a template for the PCR
array according to the array instructions using SYBR
green chemistry on an ABI 7900HT system (Applied
Biosystems, Grand Island, NY). Data were analyzed
using SABiosciences RT2 Profiler PCR Data Analysis
software at http://pcrdataanalysis.sabiosciences.com/pcr/
arrayanalysis.php and were considered significant at
> 1.3 fold change and P < 0.05. Relative quantitation for
each gene was determined by normalizing to 4 house-
keeping genes (RPLP1, HPRT1, RPL13A, and ACTB)
comparing the ID and PF groups using the 2-ΔΔCt
method. For gene expression analysis by qPCR using
SYBR green chemistry, cDNA was prepared as described
above. Primers for qPCR were designed using Primer
Express v 2.0 (Applied Biosystems) and validated if they
met the following criteria: (1) single peak on dissociation
curve and (2) amplification efficiency slope of −3.3 using
titrated standard curve. Additionally, whenever possible,
primers were designed such that the amplicon spanned
at least one intron. Relative quantitation for each gene
was determined using the 2-ΔΔCT method (Applied Bio-
systems User Bulletin #2) with Cyclophilin B (Cyclo) as
the invariant control. Primer sequences used in these
studies are listed in Additional file 1: Table S1.Statistical analysis
Comparisons of body weight, hemoglobin, hematocrit,
and array data within and between treatment groups
were analyzed using one-way ANOVA followed by Least
Significant Difference as the post hoc test using SPSS
software version 17.0 (IBM-SPSS, Chicago, IL). Differ-
ences in gene expression between ID and PF groups
within each diet were determined using a Student’s
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interval and presented as means ± SEM.
Results
Body weight and food intake
Consistent with previous observations, rats in the ID
groups consumed significantly less diet and weighed sig-
nificantly less than rats in the C groups regardless of diet
formulation (Figure 1) [15,16]. At the end of the dietary
treatment period, rats in the 76-ID group consumed 13%
less diet and weighed 10% less than the 76-C group,
whereas rats in the 93-ID group consumed 7% less diet
and weighed 5% less than the 93-C group. There were no
differences in final body weight between rats in the PF and
ID groups on either diet (Figure 1). Interestingly, rats re-
ceiving either the 76-C or 76-ID diets consumed signifi-
cantly less diet than those receiving the 93-C or 93-ID
diet, respectively.
Iron status
Importantly, only the rats in the ID groups exhibited signs
of anemia as determined by hemoglobin and hematocrit
(Figure 2). Regardless of diet, hemoglobin levels were
decreased by ~38% in the ID groups compared to C and
PF groups (Figure 2A). Similarly, rats in the 76-ID and 93-
ID groups exhibited a ~37% decline in hematocrit values
compared to the C and PF groups (Figure 2B). Because of
the similarities in hemoglobin and hematocrit between the
C and PF rats within each diet group, the remaining com-
parisons were made between the ID and PF groups for
each diet in order to attribute any observed biologicalFigure 1 Body weights and food intake were monitored throughout t
significantly less weight regardless of diet. *Indicates the day at which diffe
p < 0.05.changes to a diminished iron status rather than a decrease
in total nutrient intake. Lastly, serum iron and non-heme
liver iron was significantly lower in the ID groups com-
pared to the PF groups for both diets (Figure 3A-B).
It is of note that serum iron levels in the 93-PF group
were significantly lower than the 76-PF group
(Figure 3A). Each diet was sent to an independent labora-
tory (N·P Analytical Laboratories, St. Louis, MO) for ana-
lysis of iron content. The iron content of the 76-C and
93-C diets was 44 mg/kg and 41 mg/kg diet, respectively.
Iron content of the 76-ID and 93-ID diets was 3 mg/kg
and 2 mg/kg diet, respectively. Thus, when average daily
intake of iron is compared by diet (i.e., AIN-76 vs. AIN-
93), rats receiving the AIN-93 diet consumed less iron
those consuming the AIN-76 diet, regardless of iron level
in the diet (607.2 ± 25 μg/day for 76-PF vs. 590.8 ± 25
μg/day for 93-PF and 47.6 ± 2 μg/day for 76-ID vs. 31.2 ±
1 μg/day for 93-ID, data not shown.) Despite these differ-
ences, animals in the PF groups met the recommended
guidelines for iron intake of at least 525 μg Fe/day (based
on an intake of 15 g diet/day on a diet containing 35 mg
Fe/kg diet) [17]. Interestingly, non-heme liver iron was
not different between the 76-PF and 93-PF groups
(Figure 3B), and importantly serum iron and non-heme
liver iron did not differ between the 76-ID and 93-ID
groups (Figure 3A-B).
Steady-State serum levels of glucose, insulin,
and triacylglycerols
Serum glucose levels were higher than normal in all
groups, but were expected as a result of the method ofhe 21 d experimental period. Both the ID and PF groups gained
rences in food intake and weight gain became statistically significant,
Figure 2 Hematologic values indicate that only the ID animals in each group were anemic. Levels of hemoglobin and hematocrit did not
differ between AIN-76 and AIN-93 diets. Values are means ± SEM (n = 8). *Indicates statistical significances between groups, p < 0.05.
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tistically significant (P=0.06), serum glucose in the 76-ID
group tended to be higher when compared to the 76-PF
group (Figure 4A). In animals receiving the AIN-93 diet,
serum glucose of rats in the ID group was significantly
higher than those in the 93-PF group (P<0.05)
(Figure 4A). Serum insulin levels were increased 50%
and 100% in the 76-ID and 93-ID groups, respectively,
compared to their corresponding PF groups (P<0.05)
(Figure 4B). In order to determine if elevated glucose
levels were the result of increased circulating cortisol,
serum cortisol was determined. Compared to their re-
spective PF groups, serum cortisol levels were signifi-
cantly decreased in the 76-ID and 93-ID groups (P<0.05)
(Figure 4C). Intriguingly, dietary iron deficiency was only
associated with elevated serum levels of TAG in rats
consuming the AIN-76 diet (P<0.05) (Figure 4D).
Alterations in hepatic gene expression
Using a pathway-focused PCR array approach in addi-
tion to traditional qPCR, the expression of genes
involved in glucose and lipid metabolism was assessed in
the livers of ID and PF animals. Relative to the PF
groups, more numerous and significant changes in gene
expression were detected in the 76-ID group than the
93-ID group in the PCR array (Table 2). In terms of glu-
cose homeostasis, the most notable change in geneFigure 3 Degrees of iron deficiency did not differ between AIN-76 an
similar degrees in ID animals fed either an AIN-76 or AIN-93 diet. Values are
groups, p < 0.05.expression that was determined by the glucose metabol-
ism PCR array was a ~3.5-fold increase in glucokinase
(Gck) mRNA expression in both ID groups (Table 2). In
contrast, ATP-citrate lyase (Acly) increased 2.9-fold in
the 76-ID group compared to the 76-PF group, though
similar changes were not evident in rats receiving AIN-
93-based diets (Table 2). The alterations in gene expres-
sion of both Gck and Acly determined by the PCR array
were further validated and confirmed by qPCR
(Figure 5A-B).
Taking a more biased approach to assess iron- and/or
diet-dependent changes in gene expression, the hepatic
expression of genes involved in glucose, lipid, and iron
metabolism was also examined by qPCR. The mRNA
abundance of pyruvate dehydrogenase kinase-4 (Pdk4)
was increased ~3- and 2-fold in the 76-ID and 93-ID
groups, respectively (Figure 5A-B). Similar to the
changes in Acly gene expression observed in the 76-ID
group, the expression of lipogenic genes such as sterol
regulatory binding protein-1c (Srebp1c) and fatty acid
synthase (Fas) were also significantly increased in the
livers of the 76-ID animals compared to the 76-PF ani-
mals (Figure 5A). Compared to the 93-PF group, expres-
sion of Srebp1c and Fas was not significantly different in
the 93-ID group (Figure 5B). Interestingly, the expres-
sion of stearoyl CoA desaturase 1 (Scd1) mRNA, the
rate-limiting enzyme involved in the synthesis ofd AIN-93 diets. Serum iron and non-heme liver iron were reduced to
means ± SEM (n = 8). *Indicates statistical significance between
Figure 4 Serum levels of glucose and insulin were significantly increased, while cortisol levels were significantly decreased in the ID
groups. ID resulted in significantly increased serum triglycerides in rats consuming the AIN-76 diet, but did not have an effect on rats consuming
the AIN-93 diet. Values are given as means ± SEM (n=4-8). *Indicates statistical difference between ID and PF animals within each diet group,
p < 0.05.
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ation into TAG, was significantly decreased (~60% re-
duction) in the 76-ID group compared to the 76-PF
group (Figure 5A). Similar results were obtained for the
93-ID group, though when compared to the 93-PF
group, the results did not reach the level of statistical
significance (Figure 5B). Consistent with previous find-
ings of diminished β-oxidation activity in ID, there was
significant reduction (70 – 80%) in the gene expression
of carnitine palmitoyltransferase (Cpt1) in both ID
groups regardless of diet (Figure 5A-B) [9,10,20]. Lastly,
to further confirm that the livers were “sensing” iron de-
ficiency in animals receiving an iron-deficient diet, the
mRNA abundance of the iron uptake protein transferrin
receptor 1 (Tfr1) and the iron-sensing peptide hormone
hepcidin (Hamp1) was assessed. As expected, both the
76-ID and 93-ID groups exhibited an increased abun-
dance (4 – 7-fold) of Tfr1 mRNA compared to their re-
spective PF groups (Figure 5A-B). Expression of Hamp1
mRNA was significantly repressed (> 99% reduction) in
both ID groups compared to their PF counterparts
(Figure 5A-B).Table 2 Relative fold-change in mRNA abundance of
genes involved in glucose metabolism1
Gene Name Gene Symbol AIN-76 AIN-93
Glucokinase Gck +3.4 +3.9
ATP-citrate lyase Acly +2.9 NC




Phosphoglucomutase 3 Pgm3 +1.5 NC
Ribose 5-phosphate isomerase A Rpia +1.5 +1.4
Glycogen synthase 2 (liver specific) Gys2 −1.3 −1.6
2,3-bisphosphoglycerate mutase Bpgm −1.3 −1.4
1Values in each column indicate statistically significant relative fold-changes in
mRNA abundance in each ID group compared to their respective PF group.
NC is no change. Statistical significance was defined as fold-change ≥ 1.3 and
p < 0.05.Discussion
In the current study, despite a severe dietary iron restric-
tion, only a moderate degree of anemia (hemoglobin ~
80 g/L) was elicited. Interestingly, even a moderate in-
duction of iron deficiency appears to contribute to eleva-
tions in both steady-state levels of serum glucose and
insulin regardless of basal diet formulation. Others have
postulated that an increase in serum glucose may be
due, at least in part, to an elevation of cortisol observed
in severely anemic rats [21,22]. Interestingly, the relative
decrease in cortisol in the ID groups in the current study
suggests that other mechanisms may be responsible for
the presence of hyperglycemia. In fact, the results of this
study are in agreement with those obtained in a human
study wherein patients with severe iron deficiency exhib-
ited reduced cortisol secretion [23]. In addition to the
relative hyperglycemia, a relative hyperinsulinemia was
observed in the ID animals in both groups as well. These
metabolic adaptations presumably occur as a compensa-
tory means as ID animals preferentially utilize glucose,
rather than fat, as a metabolic substrate for peripheral
tissues as a result of decreased hemoglobin levels and
subsequent decreased oxidative capacity [4,9,10]. Thus,
blood glucose levels likely remain elevated to ensure that
adequate fuel substrate is available for energy produc-
tion, and insulin levels may remain elevated to facilitate
the entry of glucose into insulin-dependent tissues.
In an effort then to further interrogate the underlying
metabolic changes that occur with iron deficiency, we
examined the hepatic expression of 84 genes involved in
maintenance of glucose homeostasis. The level of signifi-
cance (fold change ≥ 1.3), while small, was considered
significant as previous studies have shown that dietary
intervention(s) tend to elicit somewhat modest, yet bio-
logically meaningful, transcriptional responses [24,25].
The ID rats in each group exhibited modest, but signifi-
cant alterations in the expression of genes representative
of glucose metabolism. Notable changes in gene expres-
sion include those genes associated with metabolic path-
ways including both glycolysis and gluconeogenesis and
are in agreement with the findings of others [2,10,26].
Figure 5 Iron deficiency significantly affects the hepatic expression of mRNA involved in fat metabolism (Fas, Acly, Scd1) and insulin
signaling (Pdk4 and Srebp1c). The ID group also exhibited in significantly increased expression of Tfr1 and significantly decreased expression of
the iron sensor hepcidin (Hamp1). mRNA levels were normalized to Cyclophilin B (Cyclo) mRNA as the invariant control. Numbers beneath gene
names indicate CT value ± SEM obtained for the PF group. Cyclo Mean CT = 18.9 for both PF groups. Values are given as means ± SEM (n=8).
*Indicates statistical difference between ID and PF animals within each diet group, p < 0.05.
Davis et al. Nutrition & Metabolism 2012, 9:95 Page 7 of 10
http://www.nutritionandmetabolism.com/content/9/1/95The significant increase in Gck expression is likely due
to the relative increase in circulating insulin levels
observed in the ID groups, as insulin is a known inducer
of hepatic Gck mRNA expression [27,28]. Increased ex-
pression of Gck could potentially be very important as
ID animals have been shown to have an increased reli-
ance on glucose as a metabolic substrate, and Gck is able
to rapidly increase the rate of glucose phosphorylation
in the liver in response to the elevations in blood glucose
levels [27]. Furthermore, as Gck catalyzes the first step
in hepatic glucose utilization it can contribute multiple
pathways including glycogen synthesis, glycolysis, and de
novo lipogenesis which could explain the enhanced glu-
cose utilization and hyperlipidemia reported in response
to dietary ID [2,10,26,29,30].
The significant increase in Gck mRNA expression, pre-
sumably in response to the elevated insulin levels, sug-
gests that insulin signaling in ID animals is at least
partially intact. However, previous observations suggest
that alterations in metabolic gene expression are indica-
tive of an impaired hepatic insulin response wherein ID
animals exhibited a form of mixed insulin resistance [5].
Under normal conditions (e.g., iron sufficiency) when in-
sulin levels are elevated in a fed state, insulin acts both
to repress gluconeogenic gene expression and to simul-
taneously activate lipogenic gene expression [31,32]. In
contrast, chronic hyperinsulinemia contributes to acombination of hepatic insulin resistance in which the
insulin-dependent activation of lipogenic gene expres-
sion remains intact, but gluconeogenic gene expression
is inadequately repressed [5,30,33]. In this model of
mixed insulin resistance, insulin acts through the mam-
malian target of rapamycin complex 1 to activate lipo-
genesis via a Srebp1c-dependent increase in lipogenic
gene expression, whereas insulin-induced phosphoryl-
ation of the transcription factor forkhead box protein
O1 is diminished such that gluconeogenic gene expres-
sion remains inappropriately active [33]. Thus, mixed
insulin resistance remains a candidate mechanism
explaining the relative hyperglycemia and hyperlipid-
emia reported in ID animals. Despite changes in
hepatic insulin signaling, peripheral tissue insulin
sensitivity as assessed by glucose clearance appears to
be enhanced with ID [2,4]. The extent to which there
are tissue-specific differences in insulin signaling in
response to iron deficiency warrants additional
investigation.
To further investigate potential factors contributing to
hypertriacylglycerolemia that has been reported in iron-
deficient animals, changes in hepatic lipogenic gene ex-
pression were assessed in the PF and ID groups on both
diets. In fact, it was the finding of increased lipogenic
gene expression in iron-deficient animals consuming an
AIN-76-based diet that stimulated the comparison of
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was speculated that causes of metabolic complications
observed in animals consuming an AIN-76 diet were
related to sucrose, the primary carbohydrate source in
the AIN-76 formulation [34]. Not surprisingly, basal
levels of the lipogenic genes Acly and Fas were higher in
the 76-PF group compared to the 93-PF group, though
the expression of the lipogenic master transcriptional
regulator Srebp1c remained largely unchanged. Nonethe-
less, compared to the PF group, lipogenic gene expres-
sion was further significantly enhanced only in animals
consuming an iron-deficient AIN-76 diet. Elevated levels
of TAG in the 76-ID group suggest a functional conse-
quence of enhanced lipogenic gene expression resulting
is de novo fatty acid synthesis and packaging into TAG
destined for secretion from the liver. Although the levels
of liver TAG were not determined in the present study,
taken together these data provide compelling evidence
that consumption of an iron-deficient yet high-sucrose
diet may result in more severe metabolic complications
leading to hyperglycemia, hyperinsulinemia, and
hyperlipidemia.
Despite the differences observed in lipogenic gene
expression and serum TAG between diets and consist-
ent with the findings of others that β-oxidation is
decreased in response to dietary ID, the mRNA ex-
pression of Cpt1 was found to be significantly reduced
in both the 76- and 93-ID groups. The expression of
the iron-containing enzyme Scd1 was also decreased
in the 76-ID group, with the same trend being
observed in the 93-ID group. Importantly, expression
of the mRNA encoding for the iron uptake protein
Tfr1 was significantly increased while expression of
the iron sensor Hamp1 was significantly decreased in
both ID groups. Furthermore, the relative abundance
of both Tfr1 and Hamp1 mRNA was not different be-
tween diets for either the PF or ID animals indicating
a similar response to dietary ID, regardless of basal
diet. No differences in serum iron or non-heme liver
iron between the ID groups on either diet also show
that a similar degree of iron deficiency was induced
in both ID groups. The moderate level of iron defi-
ciency achieved in this study may serve as an explan-
ation for the differences noted in lipogenic gene
expression and serum TAG. Previous work investigat-
ing the metabolic lipid response to varying degrees of
iron deficiency on an AIN-93 based diet only
observed a significant increase in serum TAG at
hemoglobin ≤ 66 g/L, a level which is consistent with
data suggesting that the severity of metabolic
responses to iron deficiency is most highly associated
with reductions in hemoglobin [2,4,8,12,35]. Interest-
ingly, despite a more modest induction of iron defi-
ciency for the current study (hemoglobin = 80 g/L),relative elevations in serum glucose and insulin levels
were still observed in both the 76-ID and 93-ID
groups.
Our findings support the work of others that have
clearly demonstrated that even a moderate induction of
iron deficiency is sufficient to disrupt normal glucose
homeostasis in rodents [2,3,8-10,12,26]. To date, rela-
tively little evidence is available for humans, but an asso-
ciation between ID and elevated hemoglobin A1C
(HbA1c) levels has been observed [36]. Indeed, as iron
status is improved, levels of HbA1c return to more nor-
mal levels [36]. Interestingly, despite what some attribute
to so-called over-nutrition, ID is also commonly
observed in overweight and obese individuals, a popula-
tion in which metabolic homeostasis is often disrupted
[37-39]. The potential for ID to contribute to or exacer-
bate conditions wherein normal glucose and fat metab-
olism are already impaired will be the focus of future
investigations.
Currently, the specific mechanisms contributing to
iron deficient-induced hyperglycemia remain elusive,
but the findings presented herein support the hypoth-
esis that a depletion of iron status, regardless of dietary
carbohydrate source, is sufficient to disrupt systemic
glucose homeostasis in a weanling rat model of iron de-
ficiency. Intriguingly, enhanced expression of the lipo-
genic genes Srebp1c, Acly, and Fas was only observed
in the ID-76 group. The extent to which these results
are suggestive of an iron-level by carbohydrate (i.e., su-
crose) interaction remains unknown and is the focus of
future studies. To this end, it will also be important to
closely examine the changes in nutrient sensing and in-
sulin signaling that occur in response to dietary iron
deficiency across different tissues such as the liver and
skeletal muscle. The significant increase in Gck expres-
sion in both ID groups provides some of the first
insight into the means by which glucose uptake and
utilization is altered in response to iron deficiency
[2,9,26]. Future work should focus on the biological sig-
nificance of this and the other somewhat modest tran-
scriptional changes that occurred with particular
attention to the allocation of glucose to various
pathways.Conclusions
Alterations in serum glucose and insulin observed in ID
animals are likely to result from an impaired iron status,
rather than the altered utilization of dietary carbohy-
drate. In contrast, the alterations observed in lipid me-
tabolism (e.g., lipogenic gene expression and serum
TAG) in response to ID may be explained by metabolic
partitioning of the excess sucrose (relative to AIN-93)
present in the AIN-76 diet.
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